IMMUNOGENICITY OF HEPATITIS A VACCINE IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Radzikowski, A. [1 ]
Banaszkiewicz, A. [1 ]
Lazowska-Przeorek, I. [1 ]
Grzybowska-Chlebowczyk, U. [2 ]
Wos, H. [2 ]
Pytrus, T. [3 ]
Iwanczak, B. [3 ]
Kowalska-Duplaga, K. [4 ]
Fyderek, K. [4 ]
Gawronska, A. [1 ]
Karolewska-Bochenek, K. [1 ]
Kotowska, M. [1 ]
Albrecht, P. [1 ]
机构：
[1] Med Univ Warsaw, Dept Pediat Gastroenterol & Nutr, Warsaw, Poland
[2] Med Univ Silesia, Dept Pediat, Katowice, Poland
[3] Wroclaw Med Univ, 2nd Dept & Clin Pediat Gastroenterol & Nutr, Wroclaw, Poland
[4] Jagiellonian Univ, Coll Med, Polish Amer Childrens Hosp, Dept Pediat Gastroenterol & Nutr, Krakow, Poland
来源：
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION | 2010年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E97 / E97
页数：1
相关论文
共 50 条
  • [31] Facing Real-World Challenges of Immunogenicity in Pediatric Inflammatory Bowel Disease
    Gress, Kyle
    Bass, Julie A.
    Funk, Ryan S.
    Morrow, Ryan P.
    Hasenkamp, Rachel
    Shakhnovich, Valentina
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [32] Response to Hepatitis A Vaccine in Children with Inflammatory Bowel Disease Receiving Infliximab
    Moses, Jonathan
    Alkhouri, Naim
    Shannon, Angela
    Feldstein, Ariel
    Carter-Kent, Christine
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (12) : E160 - E160
  • [33] HUMORAL IMMUNOGENICITY OF THREE SARS-COV-2 MRNA VACCINE DOSES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Schell, Trevor
    Knutson, Keith
    Saha, Sumona
    Wald, Arnold
    Phan, Hiep S.
    Almasry, Mazen
    Chun, Kelly Y.
    Grimes, Ian C.
    Lutz, Megan
    Hayney, Mary S.
    Farraye, Francis A.
    Caldera, Freddy
    GASTROENTEROLOGY, 2022, 162 (07) : S597 - S598
  • [34] Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease
    Schell, Trevor L.
    Knutson, Keith L.
    Saha, Sumona
    Wald, Arnold
    Phan, Hiep S.
    Almasry, Mazen
    Chun, Kelly
    Grimes, Ian
    Lutz, Megan
    Hayney, Mary S.
    Farraye, Francis A.
    Caldera, Freddy
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (11) : 1781 - 1786
  • [35] IMMUNOGENICITY AND SAFETY OF ADJUVATED RECOMBINANT ZOSTER VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON DIFFERENT IMMUNOSUPPRESSIVE THERAPIES.
    Franco, Marianna
    De Bona, Manuela
    Brun, Paola
    Piselli, Pierluca
    Savarino, Edoardo V.
    Castagliuolo, Ignazio
    Buda, Andrea
    GASTROENTEROLOGY, 2024, 166 (05) : S1448 - S1448
  • [36] Should all pediatric patients with type 1 autoimmune hepatitis be screened for inflammatory bowel disease?
    Kellermayer, Richard
    JHEP REPORTS, 2025, 7 (03)
  • [37] Hepatitis B vaccination in patients with inflammatory bowel disease
    Ruwaida Ben Musa
    Anuhya Gampa
    Sanjib Basu
    Ali Keshavarzian
    Garth Swanson
    Michael Brown
    Rana Abraham
    Keith Bruninga
    John Losurdo
    Mark DeMeo
    Sohrab Mobarhan
    David Shapiro
    Ece Mutlu
    World Journal of Gastroenterology, 2014, 20 (41) : 15358 - 15366
  • [38] Azathioprine induced hepatitis in patients with inflammatory bowel disease
    Srirajaskanthan, Rajaventhan
    Valliani, Dilshad
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (05) : 724 - 725
  • [39] Azathioprine induced hepatitis in patients with inflammatory bowel disease
    Rajaventhan Srirajaskanthan
    Dilshad Valliani
    International Journal of Clinical Pharmacy, 2011, 33 : 724 - 725
  • [40] Hepatitis B vaccination in patients with inflammatory bowel disease
    Ben Musa, Ruwaida
    Gampa, Anuhya
    Basu, Sanjib
    Keshavarzian, Ali
    Swanson, Garth
    Brown, Michael
    Abraham, Rana
    Bruninga, Keith
    Losurdo, John
    DeMeo, Mark
    Mobarhan, Sohrab
    Shapiro, David
    Mutlu, Ece
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (41) : 15358 - 15366
12345